Eli Lilly Signs $2.75B AI Drug Deal with Insilico Medicine
BEIJING — U.S. Pharmaceutical giant Eli Lilly has entered a $2.75 billion agreement with Hong Kong-based Insilico Medicine to accelerate the development and global distribution of … Read more